Organic Molecular Sensing of Cell Traction for Metastasis Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating the metastatic properties of cancer cells based on cell traction force are complex, requiring sophisticated device fabrication and data processing, making them difficult to apply in clinical settings and drug screening.
Innovation Solution
A device using an organic molecular compound that responds to cell traction force through color, fluorescence, or luminescence changes, combined with an extracellular matrix polymer, to efficiently and statistically evaluate metastatic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell traction force microscopy is used to measure cell traction force, then measurement precision is improved, but device complexity and ease of operation deteriorate due to sophisticated device fabrication and complex data processing requirements
Solution Approach 1:
The patent replaces complex mechanical measurement systems (cell traction force microscopy with sophisticated devices) with a chemical sensing system. The organic molecular compound acts as a chemical sensor that directly responds to cell traction force through color, fluorescence, or luminescence changes, eliminating the need for complex mechanical fabrication and data processing while maintaining measurement precision.
Solution Approach 2:
The patent utilizes color changes, fluorescence changes, or luminescence changes of the organic molecular compound as direct indicators of cell traction force. This optical response mechanism provides a simple, visual readout that eliminates complex data processing requirements while maintaining high measurement precision for evaluating metastatic potential.
2Measurement precision
If cell traction force microscopy is used to measure cell traction force, then measurement precision is improved, but ease of operation deteriorates due to complex data processing requirements
Solution Approach 1:
The patent replaces mechanical measurement systems requiring complex data processing with a chemical sensing system. The organic molecular compound provides direct optical responses (color, fluorescence, or luminescence changes) that can be observed and evaluated without sophisticated data processing, significantly improving ease of operation while maintaining measurement precision.
Solution Approach 2:
The organic molecular compound serves as a self-indicating sensor that automatically responds to cell traction force through visible optical changes. This self-service mechanism eliminates the need for external complex data processing systems, allowing researchers to directly evaluate metastatic potential through simple visual observation or basic instrumentation.
3Reliability
If transcriptome analysis is used to evaluate EMT, then analysis comprehensiveness is improved, but productivity and ease of operation deteriorate due to time-consuming and expertise-intensive analysis
Solution Approach 1:
The patent replaces complex transcriptome analysis (genomic/bioinformatic system) with a direct mechanical sensing approach using organic molecular compounds. The compound responds directly to cell traction force, providing rapid EMT evaluation without requiring time-consuming genomic analysis or specialized bioinformatics expertise, thereby improving both productivity and accessibility.
Solution Approach 2:
The organic molecular compound serves as a simple, inexpensive, single-use sensing element that provides rapid EMT evaluation. Unlike expensive and time-intensive transcriptome analysis requiring specialized facilities and expertise, this disposable chemical sensor enables quick assessment of metastatic potential in routine laboratory settings, dramatically improving productivity.
4Reliability
If transcriptome analysis is used to evaluate EMT, then analysis comprehensiveness is improved, but ease of operation deteriorates due to expertise requirements
Solution Approach 1:
The patent replaces complex transcriptome analysis requiring specialized genomic and bioinformatic expertise with a straightforward mechanical sensing method. The organic molecular compound directly responds to cell traction force through visible optical changes, enabling EMT evaluation by researchers without specialized genomic training, thereby improving ease of operation and accessibility.
Solution Approach 2:
The patent uses color, fluorescence, or luminescence changes of the organic molecular compound as direct visual indicators of EMT status. This visual readout mechanism eliminates the need for complex data interpretation and specialized genomic expertise, allowing any researcher to easily evaluate metastatic potential through simple observation or basic instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables simple and efficient statistical evaluation of metastatic potential in cancer cells, distinguishing highly metastatic from less metastatic cells based on visible responses.
Implementation Method 1
an organic molecular compound that responds in the form of any one of color change, fluorescence change, luminescence change, and combinations thereof by the cell traction force
Implementation Method 2
an organic molecular compound that responds in the form of any one of color change, fluorescence change, luminescence change, and combinations thereof by the cell traction force
Data Source
AI summary
The present invention provides a device and a method for evaluating the metastatic properties of cancer cells on the basis of cell traction forces of cancer cells.